Title Credit Category Series datesort descending Cost
Management of Unfavorable Intermediate-Risk Prostate Cancer: Role of SBRT, Brachytherapy and Androgen Deprivation
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Certificate of Attendance
 Sessions onDemand 03/11/2025 to 03/10/2027 $149.00
Management of Small Cell Neuroendocrine Tumors of the Genitourinary Tract
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 Certificate of Attendance
 Sessions onDemand 03/11/2025 to 03/10/2027 $149.00
Gray Zone - Unresectable Pancreatic Adenocarcinoma: Evidence-Based Medicine or a Gut Feeling?
    • 1.00 AMA PRA Category 1 Credit™
 Journal Activities 03/13/2025 to 03/12/2026 $0.00
ASTRO ROCKS: Promotion and Tenure
    • 1.00 Certificate of Attendance
 Webinars 03/14/2025 to 04/10/2027 $0.00
Implementation of a Prostate SBRT Program in the Community Setting
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 Certificate of Attendance
 Sessions onDemand 03/18/2025 to 03/17/2027 $149.00
Science Highlights 2024: Breast Cancer
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Certificate of Attendance
 Sessions onDemand 03/24/2025 to 12/31/2025 $79.00
The Hidden Risks of Artificial Intelligence (AI): Biases and Disparities in the Global Development and Deployment of AI for Cancer Care
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 Certificate of Attendance
 Sessions onDemand 03/25/2025 to 03/24/2027 $149.00
Moving Beyond Auditory Speech: Improving Equity for Patients and Providers with Diverse Communication Needs
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 Certificate of Attendance
 Sessions onDemand 03/25/2025 to 03/24/2027 $0.00
Appropriateness Criteria for Radiotherapy in the Setting of Presumed Early-stage Lung Cancer
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Certificate of Attendance
 Journal Activities 03/26/2025 to 03/25/2027 $49.00
2025 Quarter 2 - Journal Reviewer CME
    • 3.00 AMA PRA Category 1 Credit™
 Journal Activities 04/01/2025 to 07/31/2025 $0.00
Fine ART: Ever Evolving Online Adaptive Radiotherapy Technologies and Clinical Innovations
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Certificate of Attendance
 Sessions onDemand 04/01/2025 to 03/31/2027 $149.00
Prevention and Management of Toxicity in Organs at Risk (OAR) in a Community Setting
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Certificate of Attendance
 Sessions onDemand 04/08/2025 to 04/07/2027 $149.00
Gray Zone - A Blast from the Past: Definitive Management of Favorable Early Stage Hodgkin Lymphoma Ineligible for Systemic Therapy
    • 1.00 AMA PRA Category 1 Credit™
 Journal Activities 04/14/2025 to 04/13/2026 $0.00
A Randomized Study of Consolidation Chemoradiation (CTRT) versus Observation after first line chemotherapy (CT) in Advanced Gall Bladder Cancers (GBC...
    • 1.00 AMA PRA Category 1 Credit™
 Journal Activities 04/14/2025 to 04/13/2027 $49.00
Integration of HPV ctDNA Testing into Clinical Practice for HPV+ OPSCC – Ready for Prime Time?
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 Certificate of Attendance
 Sessions onDemand 04/15/2025 to 04/14/2027 $149.00

Pages